Chemoinformaics analysis of 2-(4-HYDROXYPHENYL)ETHYL-TRIMETHYLAZANIUM
| Molecular Weight | 180.271 | nRot | 3 |
| Heavy Atom Molecular Weight | 162.127 | nRig | 19 |
| Exact Molecular Weight | 180.138 | nRing | 1 |
| Solubility: LogS | -6.421 | nHRing | 0 |
| Solubility: LogP | 6.117 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 32.2743 |
| nHD | 1 | BPOL | 20.3377 |
| QED | 0.476 |
| Synth | 5.593 |
| Natural Product Likeliness | 2.983 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.926 |
| MDCK | 0.00000902 |
| BBB | 0.164 |
| PPB | 0.982134 |
| VDSS | 1.417 |
| FU | 0.0299844 |
| CYP1A2-inh | 0.043 |
| CYP1A2-sub | 0.649 |
| CYP2c19-inh | 0.16 |
| CYP2c19-sub | 0.935 |
| CYP2c9-inh | 0.168 |
| CYP2c9-sub | 0.571 |
| CYP2d6-inh | 0.552 |
| CYP2d6-sub | 0.534 |
| CYP3a4-inh | 0.751 |
| CYP3a4-sub | 0.249 |
| CL | 3.769 |
| T12 | 0.05 |
| hERG | 0.009 |
| Ames | 0.007 |
| ROA | 0.085 |
| SkinSen | 0.052 |
| Carcinogencity | 0.029 |
| EI | 0.836 |
| Respiratory | 0.837 |
| NR-Aromatase | 0.834 |
| Antiviral | No |
| Prediction | 0.797757 |